Serum transforming growth factor beta 1 in patients of renal cell carcinoma

被引：0
|
作者：
Singh, SK
Chhiber, SS
Vohra, H
Sharma, SK
机构：
来源：
JOURNAL OF UROLOGY | 2003年 / 169卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
779
引用
收藏
页码：201 / 201
页数：1
相关论文
共 50 条
  • [41] RENAL TRANSFORMING GROWTH-FACTOR-BETA-1 PRODUCTION IN NEONATE RATS
    COIMBRA, TM
    DASILVA, CGA
    LACHAT, JJ
    CELL PROLIFERATION, 1994, 27 (11) : 669 - 675
  • [42] Increased renal production of transforming growth factor-beta(1) in patients with type II diabetes
    Sharma, K
    Ziyadeh, FN
    Alzahabi, B
    McGowan, TA
    Kapoor, S
    Kurnik, BRC
    Kurnik, PB
    Weisberg, LS
    DIABETES, 1997, 46 (05) : 854 - 859
  • [43] ELEVATED LEVELS OF PLASMA TRANSFORMING GROWTH FACTOR-BETA-1 IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA
    ITO, N
    KAWATA, S
    TAMURA, S
    TAKAISHI, K
    SHIRAI, Y
    KISO, S
    TSUSHIMA, H
    MATSUZAWA, Y
    HEPATOLOGY, 1992, 16 (04) : A58 - A58
  • [44] SERUM GROWTH DIFFERENTIATION FACTOR 15 AND TRANSFORMING GROWTH FACTOR BETA 1 IN PATIENTS WITH SYSTEMIC SCLEROSIS AND EARLY REMODELING OF THE CARDIOVASCULAR SYSTEM
    Kucharz, E.
    Gieszczyk, K.
    Sikora-Puz, A.
    Mizia, M.
    Widuchowska, M.
    Kotulska, A.
    Kopec-Medrek, M.
    Chudek, J.
    Mizia-Stec, K.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S95 - S95
  • [45] The significance of serum soluble intercellular adhesion molecule 1 and transforming growth factor α in patients with nasopharyngeal carcinoma
    Yu, YQ
    Dong, WD
    Zhou, XR
    Li, SH
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2004, 130 (10) : 1205 - 1208
  • [46] CELL LINEAGE SPECIFICITY OF EXPRESSION OF THE MURINE TRANSFORMING GROWTH FACTOR-BETA-3 AND TRANSFORMING GROWTH FACTOR-BETA-1 GENES
    WATRIN, F
    SCOTTO, L
    ASSOIAN, RK
    WOLGEMUTH, DJ
    CELL GROWTH & DIFFERENTIATION, 1991, 2 (02): : 77 - 83
  • [47] Significance of the overexpression of transforming growth factor α, transforming growth factor β1 and vascular endothelial growth factor in patients with hepatocellular carcinoma.
    Song, BC
    Chung, YH
    Choi, WB
    Kim, JA
    Hong, IR
    Lee, SS
    Jung, SA
    Lee, HC
    Lee, YS
    Suh, DJ
    HEPATOLOGY, 1999, 30 (04) : 680A - 680A
  • [48] Transforming Growth Factor β1 and soluble Fas serum levels in hepatocellular carcinoma
    Sacco, R
    Leuci, D
    Tortorella, C
    Fiore, G
    Marinosci, F
    Schiraldi, O
    Antonaci, S
    CYTOKINE, 2000, 12 (06) : 811 - 814
  • [49] Serum vascular endothelial growth factor is a candidate biomarker of renal cell carcinoma in hemodialysis patients
    Ishizuka, T
    Hayashi, T
    Nakazawa, H
    Ito, F
    Nitta, K
    Horita, S
    Uchida, K
    Nihei, H
    Toma, H
    NEPHRON, 2000, 84 (01): : 83 - 84
  • [50] Transforming growth factor beta 1 levels in patients undergoing PTCA
    Gori, AM
    Falciani, M
    Giusti, B
    Fedi, S
    Capanni, M
    Simonetti, I
    Margheri, M
    Prisco, D
    Abbate, R
    Gensini, GF
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2946 - P2946
12345